PCMN
PFE icon

Paradigm Capital Management (Nevada)’s Pfizer PFE Stock Holding History

Paradigm Capital Management (Nevada)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$625K Sell
22,256
-153
-0.7% -$4.07K 0.57% 38
2025
Q4 		$558K Sell
22,409
-1,392
-6% -$35.1K 0.52% 40
2025
Q3 		$607K Sell
23,801
-15,494
-39% -$382K 0.6% 35
2025
Q2 		$953K Sell
39,295
-21,686
-36% -$506K 0.94% 30
2025
Q1 		$1.54M Sell
60,981
-25,097
-29% -$657K 1.58% 20
2024
Q4 		$2.28M Sell
86,078
-6,564
-7% -$178K 2.13% 12
2024
Q3 		$2.68M Buy
+92,642
New +$2.7M 2.57% 9
2022
Q4 		$2.82M Buy
55,038
+1,183
+2% +$56.7K 4.13% 6
2022
Q3 		$2.36M Buy
53,855
+135
+0.3% +$6.56K 3.14% 7
2022
Q2 		$2.82M Sell
53,720
-287
-0.5% -$14.6K 3.54% 7
2022
Q1 		$2.8M Buy
54,007
+304
+0.6% +$15.8K 2.82% 9
2021
Q4 		$3.17M Buy
+53,703
New +$2.66M 3.15% 8

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Paradigm Capital Management (Nevada)'s PFE Position: Q1 2026 in Review

Paradigm Capital Management (Nevada) reduced its Pfizer (PFE) stake by 0.68% in Q1 2026, selling an estimated $4.07K and leaving 22,256 shares worth $625K. The position accounts for 0.57% of the portfolio, ranked #38.

Paradigm Capital Management (Nevada) first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. The position peaked at $3.17M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Paradigm Capital Management (Nevada) held 22,256 shares of Pfizer worth $625K as of Q1 2026.
  • Paradigm Capital Management (Nevada) sold 153 Pfizer shares in Q1 2026, an estimated $4.07K.
  • Pfizer made up 0.57% of Paradigm Capital Management (Nevada)'s portfolio in Q1 2026, its #38 holding.
  • Paradigm Capital Management (Nevada) first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
  • Paradigm Capital Management (Nevada)'s Pfizer position peaked at $3.17M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q1 2026, filed 6 May 2026.